New pill aims to restore skin color in vitiligo patients
NCT ID NCT07172347
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 30 times
Summary
This study tests an experimental tablet called VC005 for people with non-segmental vitiligo, a condition that causes white patches on the skin. About 120 adults aged 18 to 70 will take the tablet or a placebo for 24 weeks to see if it helps bring back color to the face. The goal is to find a safe and effective way to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SEGMENTAL VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Peking University People's Hospital
RECRUITINGBeijing, Beijng, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.